Add Yahoo as a preferred source to see more of our stories on Google. Tumors positive for estrogen receptors are the most common subtype of breast cancer. (Douglas Olivares via Getty Images) This ...

The trial enrolled 703 participants who had previously received one or more lines of systemic therapy.

Pfizer has rolled out detailed trial data suggesting Tukysa could be part of a new first-line treatment to delay the progression of HER2-positive breast cancer. The current standard of care for the ...

A precision oncology Pfizer drug now has clinical data showing it helped patients with colorectal cancer live longer, results that study investigators say could change the way physicians treat those ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...